Catalyst Wire Dossier Catalyst Wire Dossier

MAX-002 suppository

· Forest Laboratories
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAX-002 suppository, covering 2019-08-28 to 2019-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis [Phase 3]

See pricing